Novel Oleanolic Acid-Phtalimidines Tethered 1,2,3 Triazole Hybrids as Promising Antibacterial Agents: Design, Synthesis, In Vitro Experiments and In Silico Docking Studies. 2023

Ghofrane Lahmadi, and Mabrouk Horchani, and Amal Dbeibia, and Abdelkarim Mahdhi, and Anis Romdhane, and Ata Martin Lawson, and Adam Daïch, and Abdel Halim Harrath, and Hichem Ben Jannet, and Mohamed Othman
Normandie University, URCOM, UNILEHAVRE, FR3021, UR 3221, 25 Rue Philippe Lebon, BP 540, F-76058 Le Havre, France.

As part of the valorization of agricultural waste into bioactive compounds, a series of structurally novel oleanolic acid ((3β-hydroxyolean-12-en-28-oic acid, OA-1)-phtalimidines (isoindolinones) conjugates 18a-u bearing 1,2,3-triazole moieties were designed and synthesized by treating an azide 4 previously prepared from OA-1 isolated from olive pomace (Olea europaea L.) with a wide range of propargylated phtalimidines using the Cu(I)-catalyzed click chemistry approach. OA-1 and its newly prepared analogues, 18a-u, were screened in vitro for their antibacterial activity against two Gram-positive bacteria, Staphylococcus aureus and Listeria monocytogenes, and two Gram-negative bacteria, Salmonella thyphimurium and Pseudomonas aeruginosa. Attractive results were obtained, notably against L. monocytogenes. Compounds 18d, 18g, and 18h exhibited the highest antibacterial activity when compared with OA-1 and other compounds in the series against tested pathogenic bacterial strains. A molecular docking study was performed to explore the binding mode of the most active derivatives into the active site of the ABC substrate-binding protein Lmo0181 from L. monocytogenes. Results showed the importance of both hydrogen bonding and hydrophobic interactions with the target protein and are in favor of the experimental data.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009828 Oleanolic Acid A pentacyclic triterpene that occurs widely in many PLANTS as the free acid or the aglycone for many SAPONINS. It is biosynthesized from lupane. It can rearrange to the isomer, ursolic acid, or be oxidized to taraxasterol and amyrin. Oleanol,Hederins,Oleanane Triterpenes,Triterpenes, Oleanane
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Ghofrane Lahmadi, and Mabrouk Horchani, and Amal Dbeibia, and Abdelkarim Mahdhi, and Anis Romdhane, and Ata Martin Lawson, and Adam Daïch, and Abdel Halim Harrath, and Hichem Ben Jannet, and Mohamed Othman
April 2019, European journal of medicinal chemistry,
Ghofrane Lahmadi, and Mabrouk Horchani, and Amal Dbeibia, and Abdelkarim Mahdhi, and Anis Romdhane, and Ata Martin Lawson, and Adam Daïch, and Abdel Halim Harrath, and Hichem Ben Jannet, and Mohamed Othman
November 2019, Bioorganic chemistry,
Ghofrane Lahmadi, and Mabrouk Horchani, and Amal Dbeibia, and Abdelkarim Mahdhi, and Anis Romdhane, and Ata Martin Lawson, and Adam Daïch, and Abdel Halim Harrath, and Hichem Ben Jannet, and Mohamed Othman
July 2024, Bioorganic chemistry,
Ghofrane Lahmadi, and Mabrouk Horchani, and Amal Dbeibia, and Abdelkarim Mahdhi, and Anis Romdhane, and Ata Martin Lawson, and Adam Daïch, and Abdel Halim Harrath, and Hichem Ben Jannet, and Mohamed Othman
September 2017, Bioorganic & medicinal chemistry letters,
Ghofrane Lahmadi, and Mabrouk Horchani, and Amal Dbeibia, and Abdelkarim Mahdhi, and Anis Romdhane, and Ata Martin Lawson, and Adam Daïch, and Abdel Halim Harrath, and Hichem Ben Jannet, and Mohamed Othman
June 2016, European journal of medicinal chemistry,
Ghofrane Lahmadi, and Mabrouk Horchani, and Amal Dbeibia, and Abdelkarim Mahdhi, and Anis Romdhane, and Ata Martin Lawson, and Adam Daïch, and Abdel Halim Harrath, and Hichem Ben Jannet, and Mohamed Othman
December 2019, Bioorganic & medicinal chemistry,
Ghofrane Lahmadi, and Mabrouk Horchani, and Amal Dbeibia, and Abdelkarim Mahdhi, and Anis Romdhane, and Ata Martin Lawson, and Adam Daïch, and Abdel Halim Harrath, and Hichem Ben Jannet, and Mohamed Othman
April 2024, Heliyon,
Ghofrane Lahmadi, and Mabrouk Horchani, and Amal Dbeibia, and Abdelkarim Mahdhi, and Anis Romdhane, and Ata Martin Lawson, and Adam Daïch, and Abdel Halim Harrath, and Hichem Ben Jannet, and Mohamed Othman
January 2024, Journal of biochemical and molecular toxicology,
Ghofrane Lahmadi, and Mabrouk Horchani, and Amal Dbeibia, and Abdelkarim Mahdhi, and Anis Romdhane, and Ata Martin Lawson, and Adam Daïch, and Abdel Halim Harrath, and Hichem Ben Jannet, and Mohamed Othman
April 2013, European journal of medicinal chemistry,
Ghofrane Lahmadi, and Mabrouk Horchani, and Amal Dbeibia, and Abdelkarim Mahdhi, and Anis Romdhane, and Ata Martin Lawson, and Adam Daïch, and Abdel Halim Harrath, and Hichem Ben Jannet, and Mohamed Othman
October 2014, European journal of medicinal chemistry,
Copied contents to your clipboard!